She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
SNV4818, the oral drug, is pan-mutant–selective PI3K? inhibitor aimed at treating HR+/HER2- breast cancer and potentially other solid tumors
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The facility is expected to become operational by FY2028-29
The new solution combines Watchmaker Genomics’ high-performance NGS chemistry with Volta’s digital fluidics platform
Subscribe To Our Newsletter & Stay Updated
